Sarcoma

Top Story

FDA grants orphan drug designation to tazemetostat for soft tissue sarcoma

June 21, 2017

The FDA granted orphan drug designation to tazemetostat for the treatment of patients with soft tissue sarcoma, according to the drug’s manufacturer.

Tazemetostat (Epizyme), a first-in-class EZH2 inhibitor, is being evaluated in an ongoing phase 2 study for the treatment of follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), mesothelioma and certain molecularly defined solid tumors.

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist, also will serve as…

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” HemOnc Today

Oral contraceptive use does not increase long-term cancer risk

June 14, 2017
Women who used oral contraceptives did not demonstrate increased long-term cancer risk, according to results of the Royal College of General Practitioner’s Oral…
CNE CME

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Video
Meeting News Coverage

VIDEO: New approaches demonstrate potential to exploit immune system to treat cancer

April 30, 2016
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
FDA News

FDA grants orphan drug designation to tazemetostat for soft tissue sarcoma

June 21, 2017
The FDA granted orphan drug designation to tazemetostat for the treatment of patients with soft tissue sarcoma, according to the drug’s…

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist…

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” …

Oral contraceptive use does not increase long-term cancer risk

June 14, 2017
Women who used oral contraceptives did not demonstrate increased long-term cancer risk, according to results of the Royal College of General…

Meeting NewsVideo

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
CHICAGO — Jarushka Naidoo, MBBCh, spoke with HemOnc Today at the ASCO Annual Meeting about the Institute for Clinical Immuno-Oncology. The…

FDA News

FDA rejects Coherus application for proposed biosimilar to Neulasta

June 12, 2017
The FDA denied approval of Coherus BioSciences’ biologics license application for CHS-1701, a proposed biosimilar for pegfilgrastim. Like…

Lineberger Comprehensive Cancer Center director to lead NCI

June 12, 2017
President Donald J. Trump selected Norman E. “Ned” Sharpless, MD, to serve as director of NCI. Sharpless — recognized for his…

Foundation Medicine announces participation in NCI-MATCH trial

June 7, 2017
Foundation Medicine, NCI and ECOG-ACRIN Cancer Research Group entered a collaboration to evaluate the benefit of genomically guided treatments…

Editorial

‘Special focus’ required to eliminate disparities among millennials with cancer

HemOnc Today, June 10, 2017
John Sweetenham, MD
Last week was a first for me — I participated in a Facebook live event. I had no idea what to expect, but a group of very smart — and…

Meeting News

Genomic testing may guide personalized care for advanced cancer

June 4, 2017
CHICAGO — Routine genomic testing of tumor samples appears feasible and enabled more personalized treatment, according to the results of the…

More Headlines »
Advertisement
Advertisement